BEAT-SHOCK Registry

NCT07643610 | Recruiting

• 1 other identifier: BEAT SHOCK
• Study Type: observational
• Target: 8,000
• Locations: 1 country
• Sites: 1

Brief Summary

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Conditions

Cardiogenic Shock; Myocardial Infarction (MI); Fulminant Myocarditis; Acute Decompensated Heart Failure; Severe Valvular Disease; Post-cardiotomy; Perioperative Cardiogenic Shock

Keywords

cardiogenic shock; Myocardial infarction (MI); Fulminant myocarditis; Acute decompensated heart failure; Severe valvular disease; Post-cardiotomy or perioperative cardiogenic shock; wide range of cardiogenic shock etiologies

Outcome Measures

Primary Outcomes (1)

• In-Hospital all-cause mortality occurring before discharge from the participating study centre

  In-hospital all-cause mortality is defined as death occurring before discharge from the participating study centre. Deaths occurring after transfer to an external hospital are not counted as in-hospital deaths, but are captured through follow-up for 30-day and 90-day mortality.

  10 years

Secondary Outcomes (3)

• 30-day and 90-day all-cause Mortality

  30, 90 days

• Need for organ support at any time during hospitalization

  30, 60, 360 days

• Acute kidney injury (AKI) within 36 hours after index diagnosis of cardiogenic shock/index presentation

  Within 36 hours after index diagnosis of cardiogenic shock/ index presentation.

Interventions

no internvention OTHER

This is a health data registry.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients who are treated at the University Hospital Basel and are diagnosed with cardiogenic shock, irrespective of underlying etiology or therapeutic strategy. The registry includes a wide range of cardiogenic shock etiologies, including: * Myocardial infarction (MI) * Fulminant myocarditis * Acute decompensated heart failure * Severe valvular disease * Post-cardiotomy or perioperative cardiogenic shock

You may not qualify if:

• Age \<18 years
• Refusal to provide informed consent by the patient or their legally authorized representative

Sponsors & Collaborators

• University Hospital, Basel, Switzerland: lead

Study Sites (1)

University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

RECRUITING

MeSH Terms

Conditions

Shock, Cardiogenic; Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis; Shock

Central Study Contacts

Jasper Boeddinghaus, PD Dr. med.

CONTACT

0041613287897; jasper.boeddinghaus@usb.ch

Gregor Leibundgut, Prof. Dr.

CONTACT

0041613287897; gregor.leibundgut@usb.ch

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 5 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 29, 2026
• First Posted: June 11, 2026
• Study Start: October 1, 2025
• Primary Completion (Estimated): October 1, 2035
• Study Completion (Estimated): October 1, 2035
• Last Updated: June 11, 2026

Record last verified: 2026-06

Locations

CH (1)